Literature DB >> 10664604

Anandamide - the other side of the coin.

P M Zygmunt1, I Julius, I Di Marzo, E D Högestätt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10664604     DOI： 10.1016/s0165-6147(99)01430-3

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN： 0165-6147            Impact factor:   14.819


× No keyword cloud information.
  11 in total

1.  Opposing roles for cannabinoid receptor type-1 (CB₁) and transient receptor potential vanilloid type-1 channel (TRPV1) on the modulation of panic-like responses in rats.

Authors:  Plínio C Casarotto; Ana Luisa B Terzian; Daniele C Aguiar; Hélio Zangrossi; Francisco S Guimarães; Carsten T Wotjak; Fabrício A Moreira
Journal:  Neuropsychopharmacology       Date:  2011-09-21       Impact factor: 7.853

2.  Anandamide activates peripheral nociceptors in normal and arthritic rat knee joints.

Authors:  S D Gauldie; D S McQueen; R Pertwee; I P Chessell
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

Review 3.  Cannabinoids and cancer: pros and cons of an antitumour strategy.

Authors:  Maurizio Bifulco; Chiara Laezza; Simona Pisanti; Patrizia Gazzerro
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

Review 4.  Vanilloid receptor ligands: hopes and realities for the future.

Authors:  A Szallasi
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

5.  Stimulation of pulmonary vagal C-fibres by anandamide in anaesthetized rats: role of vanilloid type 1 receptors.

Authors:  You Shuei Lin; Lu-Yuan Lee
Journal:  J Physiol       Date:  2002-03-15       Impact factor: 5.182

Review 6.  Cannabinoids and neuroprotection.

Authors:  R I Grundy; M Rabuffetti; M Beltramo
Journal:  Mol Neurobiol       Date:  2001 Aug-Dec       Impact factor: 5.590

Review 7.  Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels.

Authors:  Luciano De Petrocellis; Vincenzo Di Marzo
Journal:  J Neuroimmune Pharmacol       Date:  2009-10-22       Impact factor: 4.147

8.  Expression and purification of orphan cytochrome P450 4X1 and oxidation of anandamide.

Authors:  Katarina Stark; Miroslav Dostalek; F P Guengerich
Journal:  FEBS J       Date:  2008-07       Impact factor: 5.542

9.  Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB(1) and TRPV1 receptors.

Authors:  Maria Grazia Morgese; Tommaso Cassano; Vincenzo Cuomo; Andrea Giuffrida
Journal:  Exp Neurol       Date:  2007-08-22       Impact factor: 5.330

10.  Effects of glutamate NMDA and TRPV1 receptor antagonists on the biphasic responses to anandamide injected into the dorsolateral periaqueductal grey of Wistar rats.

Authors:  Manoela V Fogaça; Felipe V Gomes; Fabrício A Moreira; Francisco S Guimarães; Daniele C Aguiar
Journal:  Psychopharmacology (Berl)       Date:  2012-11-27       Impact factor: 4.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.